Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuitive Surgical
ISRG
|
+$753M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$711M |
| 3 |
Humana
HUM
|
+$617M |
| 4 |
NextEra Energy
NEE
|
+$610M |
| 5 |
British American Tobacco
BTI
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.32B |
| 2 |
STJ
St Jude Medical
STJ
|
+$690M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$629M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$609M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$603M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 9.39% |
| 2 | Technology | 9.09% |
| 3 | Healthcare | 7.39% |
| 4 | Energy | 7.04% |
| 5 | Consumer Discretionary | 6.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Advanced Energy
AEIS
$10.1B
| $16.2M | ﹤0.01% |
236,514
-65,774
| -22% | -$4.06M |
|
|
ESRX
2027
CALL
DELISTED
Express Scripts Holding Company
ESRX
| $16.2M | ﹤0.01% |
245,800
+18,500
| +8% | +$1.27M |
|
2028
PUT
Eli Lilly
LLY
$1.08T
| $16.2M | ﹤0.01% |
192,600
-447,500
| -70% | -$35.8M |
|
2029
CALL
Viatris
VTRS
$20.8B
| $16.2M | ﹤0.01% |
415,500
+126,700
| +44% | +$5.11M |
|
2030
Prudential
PUK
$36.4B
| $16.2M | ﹤0.01% |
394,175
+15,201
| +4% | +$597K |
|
2031
CALL
Direxion Daily Small Cap Bull 3x ETF
TNA
$1.27B
| $16.2M | ﹤0.01% |
305,600
-283,800
| -48% | -$14.8M |
|
2032
Neurogene
NGNE
$672M
| $16.2M | ﹤0.01% |
48,392
-49
| -0.1% | -$17.2K |
|
2033
PUT
Abbott
ABT
$187B
| $16.1M | ﹤0.01% |
363,012
-176,788
| -33% | -$7.64M |
|
2034
Honda
HMC
$39.8B
| $16.1M | ﹤0.01% |
531,795
+51,448
| +11% | +$1.59M |
|
2035
PUT
Kroger
KR
$36.7B
| $16.1M | ﹤0.01% |
545,600
-297,500
| -35% | -$9.5M |
|
2036
Apple Hospitality REIT
APLE
$3.97B
| $16.1M | ﹤0.01% |
842,153
+22,954
| +3% | +$453K |
|
2037
Oil States International
OIS
$466M
| $16.1M | ﹤0.01% |
484,746
+2,880
| +0.6% | +$106K |
|
2038
Natural Resource Partners
NRP
$1.31B
| $16.1M | ﹤0.01% |
444,218
-46,784
| -10% | -$1.76M |
|
|
SNLN
2039
DELISTED
Highland/iBoxx Senior Loan ETF
SNLN
| $16M | ﹤0.01% |
864,138
-931,048
| -52% | -$17.4M |
|
2040
PUT
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$259M
| $16M | ﹤0.01% |
20
+15
| +300% | +$17.2M |
|
2041
Cemex
CX
$16.9B
| $16M | ﹤0.01% |
1,831,944
-294,694
| -14% | -$2.48M |
|
|
FTR
2042
DELISTED
Frontier Communications Corp.
FTR
| $16M | ﹤0.01% |
497,285
-355,310
| -42% | -$16.3M |
|
2043
PUT
Novartis
NVS
$302B
| $15.9M | ﹤0.01% |
239,605
-7,254
| -3% | -$483K |
|
|
PVG
2044
DELISTED
PRETIUM RESOURCES INC.
PVG
| $15.9M | ﹤0.01% |
1,486,432
+630,946
| +74% | +$6.66M |
|
2045
PUT
Accenture
ACN
$106B
| $15.9M | ﹤0.01% |
132,700
-25,900
| -16% | -$3.09M |
|
2046
iShares Global Infrastructure ETF
IGF
$10.9B
| $15.9M | ﹤0.01% |
375,358
-16,026
| -4% | -$649K |
|
2047
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.13B
| $15.9M | ﹤0.01% |
207,494
+1,102
| +0.5% | +$83.5K |
|
2048
CALL
Applied Materials
AMAT
$347B
| $15.8M | ﹤0.01% |
407,000
-514,600
| -56% | -$18.5M |
|
2049
Sarepta Therapeutics
SRPT
$1.64B
| $15.8M | ﹤0.01% |
532,892
+294,529
| +124% | +$9.12M |
|
2050
CALL
Newmont
NEM
$96.2B
| $15.8M | ﹤0.01% |
478,300
-1,215,600
| -72% | -$42.5M |
|
Similar funds
Goldman Sachs's Q1 2017 Portfolio in Review
As of Q1 2017, Goldman Sachs held 7,322 positions worth $369B, up 4.2% from $354B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Goldman Sachs's Q1 2017 filing shows 455 new, 2,594 increased, 3,387 reduced and 597 closed positions. Its largest new stake was Deutsche Bank Aktiengesellschaft: 36,861,723 shares worth $87M. The largest sale was NVIDIA, an estimated $1.32B.
By sector, the portfolio is most concentrated in Financials at 9.4% of assets, down from 9.9% a quarter earlier, followed by Technology and Healthcare.
- Goldman Sachs's largest Q1 2017 buy was Deutsche Bank Aktiengesellschaft: 36,861,723 shares worth $87M.
- Goldman Sachs added most to Intuitive Surgical in Q1 2017, an estimated $753M increase.
- Goldman Sachs's biggest Q1 2017 reduction was NVIDIA, cutting an estimated $1.32B.
- Goldman Sachs fully exited St Jude Medical in Q1 2017, selling an estimated $690M.
- Goldman Sachs's ten largest holdings make up 16% of its $369B portfolio in Q1 2017.
- Goldman Sachs opened 455 new positions and closed 597 in Q1 2017.
- Goldman Sachs's portfolio value rose 4.2% quarter-over-quarter to $369B.
Based on Goldman Sachs's 13F filing for Q1 2017, filed 15 May 2017.